Tag: bci-reimbursement

1 article

Policy & Regulation

Neuralink hires its first federal lobbyists, with former House Ways and Means Rep. Ron Kind on the brain-computer interface coverage account

Newly filed federal disclosures show that Neuralink has engaged Jeffrey J. Kimbell & Associates and Arnold & Porter Kaye Scholer as its first registered federal lobbyists, with both firms beginning work at the end of April 2026. The scope explicitly names brain-computer interface development and commercialisation plus 'coverage of such devices' as the lobbying focus. The team on the Arnold & Porter side includes former 13-term Wisconsin Democratic Rep. Ron Kind, Senior Counsel at the firm since January 2024 and a former House Ways and Means Committee member overseeing Medicare payment programs. The hire is the first publicly visible step Neuralink has taken toward US Medicare reimbursement positioning for the N1 implant.

Jun 3